FDA
-
-
-
-
-
-
-
Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2025 Results
-
-
-
-
-
-
-
BofA Securities Downgrades Perspective Therapeutics Inc (CATX) to Neutral
-
-
-
-
-
-
-
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
-
-
-
-
-
-
-
Perspective Therapeutics (CATX) Enters into Strategic Agreements with Lantheus (LNTH) Including Equity Investment, Co-Development Options
-
-
-
-
-
-
335,194 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


